Australia - English
Straumann® Pro Arch
Tailored to fit. Designed to last.
Straumann® Pro Arch enables personalized treatment protocols for implant-borne fixed full-arch restorations. Leverage the Straumann Dental Implant System combined with the Prosthetics portfolio to treat different clinical situations with predictable outcomes.1-6
-
Treatment optionsVariety of treatment options to address specific indications and different patient’s needs.
-
SLActive® for compromised patientsPeace of mind treating even compromised patients with diabetes, cancer or smokers. Learn more about SLActive® >
-
Ultimate restorative flexibilityStraumann® prosthetic portfolio addresses patient’s high esthetic expectations and financial resources.
-
Reduced invasiveness with Roxolid®Narrow and short implants enable clinicians to preserve the bone and avoid bone grafting in some clinical situations with low bone volume. Learn more about Roxolid® >
-
Practice growthImmediate loading offering, patient communication and practice growth tools can support your practice growth.
Join our Instagram Edentulous channel @straumann.edentulous
for updates on full-arch products & technologies, tips & tricks, events, great cases and and much more!
Pro Arch step by step animation
Seamless integration and efficiency at every stage.
Straumann® ImmediaXy™ covers all stages of an immediate treatment workflow: data acquisition, planning & design, surgery and restoration and provides an end-to-end solutions.
Learn more about our immediate treatment solutions
Straumann®
Smile in a Box
Gain time and cost efficiency
Our digital, modular, integrated treatment planning and manufacturing service to cover your surgical and prosthetic indications. You select the services you require, and we deliver everything you need for your treatment in one box. Your modular alternative to in-house production.
Straumann® Pro Arch BLX
New confidence, flexibility and efficiency with one system.
One system for most full-arch challenges of the immediate full-arch rehabilitation. Straumann® BLX implant is designed for primary stability and offers you treatment flexibility with the high-performance Roxolid®1, 2 combined with the clinically proven SLActive®3-6 and provides confidence beyond immediacy.
Straumann® Pro Arch BLT
Versatility and predictability.
The Straumann® Bone Level Tapered (BLT) Implant delivers proven reliable primary stability1-3. BLT is a powerful combination of Roxolid®, SLA® and SLActive®, Bone Control Design™, CrossFit® connection, prosthetic diversity, and an apically tapered design.
The tapered form compresses the underprepared osteotomy and is designed to let you effectively master the challenges of full-arch rehabilitation.
Case videos
What clinicians say
New articles on Pro Arch
Webinars
Downloads
References
1 Eckert SE, Hueler G, Sandler N, Elkattah R, McNeil DC. Immediately Loaded Fixed Full-Arch Implant-Retained Prosthesis: Clinical Analysis When Using a Moderate Insertion Torque. Int J Oral Maxillofac Implants. 2019 Jan 31.
2 Eskan M. A., Yilmaz S., Uzel G. 2019 A Fixed Reconstruction of Complete Edentulous Patient with Immediate Function Using A New Implant Design: A Retrospective Clinical Study. Data presented during 34th Annual Meeting of the Academy of Osseointegration’s, March 13 – 16 in Washington, USA
3 Dard M, Kuehne S, Obrecht M, Grandin M, Helfenstein J, Pippenger BE Integrative Performance Analysis of a Novel Bone Level Tapered Implant. Adv Dent Res. 2016 Mar;28(1):28-33.
4 Müller F et al. Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlled trial. (2015). BMC Oral Health. 2015 Oct 12;15(1):123.
5 Nicolau P, Guerra F, Reis R, Krafft T, Benz K, Jackowski J. 10-year outcomes with immediate and early loaded implants with a chemically modified SLA surface. Quintessence Int. 2018 Dec 18:2-12
6 Heberer S, Kilic S, Hossamo J, Raguse J-D, Nelson K. Rehabilitation of irradiated patients with modified and conventional sandblasted, acid-etched implants: preliminary results of a split-mouth study. Clin. Oral Impl. Res. 22, 2011; 546–551.